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Early glottic cancer can be effectively treated with radiation or surgery, but recurrence is a 
possibility when using any of the treatment modalities.
Aim: To assess the outcome of radiotherapy as initial treatment in the control of squamous cell 
carcinoma of vocal cord (T1) and the effectiveness of salvage surgery (endoscopic or open) after 
treatment failure.
Materials and Methods: A retrospective study was based on the analysis of medical records from 
43 patients with T1 squamous cell carcinoma of the glottis, radiotherapy as initial treatment and 
follow-up period of five years.
Results: The rate of recurrence after radiotherapy was 30.2% of the cases, mean diagnosis interval 
was 29.5 months. As an option for salvage treatment, patients underwent open partial laryngectomy 
or endoscopic surgery with control rates of 77.7% and 25% respectively.
Conclusion: Our cases showed high rates of recurrence after radiotherapy and open partial 
laryngectomy was more effective for the salvage surgery.
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INTRODUCTION
Malignant laryngeal neoplasm is one of the most 
frequent diseases of the head and neck, and in 90% of 
the cases it is represented by the epidermoid carcinoma 
and its genesis is directly associated with alcohol drinking 
and smoking.
It more frequently affects the glottis - 64% of the 
cases, and any epithelial disarray or change caused by the 
tumor will change the vibratory movements of the vocal 
folds, causing dysphonia. Of all the glottis tumors, 56% 
are diagnosed in their initial stages (T1)1.
The primary glottis cancer can be effectively treated 
with radiotherapy or surgery (endoscopic or open) and 
it bears some of the best cure rates among the malignant 
neoplasms of the aerodigestive tract. In the series publi-
shed by Davis et al.2, they reported a local control rate 
of 93% in patients with glottic T1 tumors submitted to 
surgery and 67% in T1 patients submitted to radiotherapy. 
Nonetheless, when we consider only the T1a stage tumors, 
some authors report similar control rates with cordectomy 
and radiotherapy, 84% and 77% respectively.3
Treatment must not be restricted only to curing the 
cancer, which is the main objective, but one must also 
attempt to preserve breathing, swallowing and phonation.
OBJECTIVE
To assess the results of radiotherapy as the initial 
treatment mode in controlling the epidermoid carcinoma 
of the vocal fold (T1) and the efficacy of surgical salvage 
(endoscopic or open) after initial treatment failure.
MATERIALS AND METHODS
The present study was approved by the Ethics in 
Research Committee of the institution to which this study 
is associated, under registration number 0353/10.
In this series we retrospectively assessed the charts 
from 43 patients with T1 stage glottis epidermoid carcino-
ma (42 men and 1 woman), submitted to radiotherapy as 
initial treatment, who were first seen by a doctor between 
1990 and 2002.
All the patients were sorted according to the TNM-
UICC 2002 classification, after indirect laryngoscopy obtai-
ned by tele-laryngoscopy and/or nasal fibroscopic laryn-
goscopy (saved in video) and diagnostic confirmation of 
the epidermoid carcinoma through biopsy/frozen section.
We took off the sample those patients who had been 
previously treated in other services, those with tumors 
bearing other clinical stages and those with tumors of 
histological lineage other than the epidermoid carcinoma.
The routine in our service is to present all treatment 
options (radiotherapy or surgery) to patients with T1 glot-
tic carcinoma, explaining the respective pros and cons; 
nonetheless, surgery is our treatment of choice for these 
cases. Radiation treatment was based on external beam at 
the dose of 6,000 to 6,800 rad in 30-34 fractions, indicated 
according to two basic criteria:
• Patient clinically ineligible for surgery (n=12 / 
28%)
• Patient’s wish (n=31 / 72%)
In order to analyze the results obtained by radio-
therapy, the patients were grouped according to primary 
tumor localization on the vocal folds as follows: 
• Group A - T1a: Tumor not involving the anterior 
commissure (n=22).
• Group B - T1b: Tumor involving the anterior 
commissure with or without invasion of the contralateral 
fold anterior third (n=21).
After radiotherapy, all the patients were followed 
up for a period of five years or more, and in the first six 
months they returned monthly to the clinic. For clinical 
control we did indirect laryngoscopy with the goal of 
identifying any suspicious lesions early on. After tumor 
recurrence diagnosis, the situation was recorded in the 
patient’s chart and the patient was referred to salvage tre-
atment as soon as possible, which first option was partial 
open laryngectomy (frontolateral vertical) in the cases with 
or without commissure involvement. Patients with T1a 
tumors upon recurrence who were clinically unfit were 
submitted to an endoscopic tumor resection (transmuscular 
cordectomy), since it is an approach with less morbidity 
than open surgery.
RESULTS
The patients submitted to radiotherapy (N=43) to 
treat initial glottic cancer had local recurrence in 30.2% 
(N=13) of the cases. Everyone who had recurrences was 
male with an average age of 58.9 years. The mean time 
between radiotherapy onset and local recurrence diagnosis 
was 29.5 months. The most frequent histology type was the 
moderately differentiated epidermoid carcinoma (76.9%), 
followed by the well differentiated type (23.1%).
As to primary tumor location, initial radiotherapy 
treatment had the following recurrences: In Group A, 
where the initial lesion did not involve the anterior com-
missure, there was recurrence in 31.8% (n=7) of the cases 
(Table 1); in Group B, in which the initial lesion invaded 
the anterior commissure with or without involvement of 
the contralateral vocal fold, the recurrence rate was 28.5% 
(n=6), slightly lower than that of the previous group, when 
radiotherapy was carried out (Table 2).
As soon as the failure in radiotherapy was confir-
med, the patients were once again staged, being similar 
to the staging before radiotherapy with no loco regional 
metastasis. Four patients were referred to salvage endos-
copic surgery (transmuscular cordectomy), because they 
were clinically unfit. Nine patients were submitted to open 
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Of the recurrence cases treated endoscopically 
(n=4), only one was cured, the remaining patients (n=3) 
were referred to total laryngectomy because of a new 
recurrence. In this group, one patient died of cancer.
In the cases submitted to open surgery, the cure 
rate was higher, and 77.7% (n=7) patients benefited from 
surgery. 22.2 %( n=2) of the patients had new treatment 
failure and were referred to total laryngectomy. In this 
group we also had one patient dying of cancer.
DISCUSSION
The treatment of laryngeal cancer must always 
associate oncologic efficiency with function preservation. 
Traditionally, initial glottic carcinomas (T1) can be effec-
tively treated through surgery or radiotherapy, with high 
local control and survival rates4,5. Despite radiotherapy’s 
complications such as persistent edema, glottic stenosis 
or hypothyroidism, its advantage is that phonation and 
swallowing disorders are usually less impacting that the 
surgical procedures6,7. According to Brasil et al.8,9, while 
radiotherapy tends to keep the glottic region as the sound 
source, in patients submitted to surgery such source tends 
to shift to the supraglottic region, with a worsening in vocal 
quality, but keeping a socially acceptable voice, especially 
when there is speech therapy associated.
According to Bron et al.3, T1a carcinomas had 
similar local control in 5 years with radiotherapy or cor-
dectomy, 77% and 84% respectively. In T1b carcinomas, 
radiotherapy had lower success rates when compared 
to surgery (supra-cricoid partial laryngectomy), 66% and 
100% respectively. Other papers report 80 to 95%10,11 
success rate of radiotherapy in T1 laryngeal carcinomas. 
Our results with radiotherapy to treat T1a and T1b tumors 
showed high rates of recurrence. Therefore, we believe 
that surgical treatment is the best option to control this 
disease, especially in T1b cases with anterior commissure 
invasion suspicion.
There is a current trend towards performing more 
conservative surgical procedures in cases of tumor re-
currence after radiotherapy, instead of doing a total 
laryngectomy. In a study carried out by Schwaab et al.12, 
patients with initial glottic tumors (T1a, T1b and T2 with 
preserved vocal cord mobility) who had recurrence after 
radiotherapy were submitted to total or partial laryngec-
tomy (vertical or subtotal with crico-hyoid-pexia) with 77% 
and 100% loco regional control in 5 years, respectively. 
According to Ganly et al.13, patients with recurrence after 
radiotherapy for initial tumors, treated by total or partial 
laryngectomy, had global survival rates of 50% and 89%, 
respectively, with similar rates of complications, showing 
that there can be good disease control and preservation of 
laryngeal functions with partial surgery, when feasible14.
Among partial laryngectomies, the endoscopic 
approach in cases of post-radiotherapy recurrence must 
be avoided, having in mind the low rate of loco regional 
disease control, besides missing on an opportunity to 
do an open surgery with partial laryngeal preservation, 
as shown in the present study. This is explained by the 
difficulty in establishing lesion margins in an accurately 
way in a previously irradiated larynx, associated with the 
limitation of achieving broad margins.
CONCLUSION
In our cases, initial glottic tumors (T1) treated by 
radiotherapy had high rates of recurrence. This can be a 
treatment option, but the patient must be aware that higher 
cure rates can be achieved through surgery.
Open partial laryngectomy without neck dissection 
is an efficient option to treat glottic cancer after radiothe-
rapy failure in patients who remain in stages T1a or T1b, 
bearing satisfactory cancer control without the mutilation 
of a total laryngectomy.
Table 1. Group A (T1a): treatment by radiotherapy versus 
tumor recurrence.
Recurrence  Radiotherapy
N %
With recurrence 7 31,8
Without recurrence 15 68,2
Total 22 100
Table 2. Group B (T1b): treatment by radiotherapy versus 
tumor recurrence.
Recurrence  Radiotherapy
N %
With recurrence 6 28,5
Without recurrence 15 71,5
Total 21 100
surgery (vertical-frontolateral laryngectomy) without neck 
dissection (Table 3).
Table 3. Local recurrence according to treatment.
Recurrence  Treatment Total
 Open surgery
 Endoscopic 
procedure
Cured 77,7% (n=7) 25% (n=1) 69,20%
Uncured 22,2% (n=2) 75% (n=3) 30,80%
Total N = 9 N=4 N=13
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